Login / Signup

Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials.

Yongliang JiaY LaoHongmei ZhuN LiSiu-Wai Leung
Published in: Obesity reviews : an official journal of the International Association for the Study of Obesity (2018)
This meta-analysis showed that repaglinide and metformin would be the most efficacious oral drugs for first-line monotherapy of T2DM.
Keyphrases
  • systematic review
  • type diabetes
  • glycemic control
  • meta analyses
  • cardiovascular disease
  • open label
  • combination therapy
  • drug induced
  • randomized controlled trial
  • clinical trial
  • study protocol
  • weight loss